I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 18 studies | 25% ± 10% | |
| B cell | 12 studies | 24% ± 8% | |
| naive B cell | 11 studies | 23% ± 6% | |
| oligodendrocyte precursor cell | 9 studies | 28% ± 13% | |
| memory B cell | 8 studies | 19% ± 3% | |
| CD16-negative, CD56-bright natural killer cell, human | 7 studies | 21% ± 5% | |
| fibroblast | 7 studies | 19% ± 4% | |
| GABAergic neuron | 7 studies | 38% ± 20% | |
| glutamatergic neuron | 7 studies | 42% ± 27% | |
| natural killer cell | 6 studies | 22% ± 3% | |
| neuron | 6 studies | 31% ± 13% | |
| interneuron | 6 studies | 37% ± 22% | |
| macrophage | 6 studies | 23% ± 5% | |
| microglial cell | 6 studies | 22% ± 4% | |
| epithelial cell | 6 studies | 28% ± 10% | |
| retina horizontal cell | 6 studies | 26% ± 11% | |
| astrocyte | 6 studies | 32% ± 12% | |
| endothelial cell of lymphatic vessel | 5 studies | 21% ± 3% | |
| T cell | 4 studies | 16% ± 1% | |
| basal cell | 4 studies | 25% ± 9% | |
| gamma-delta T cell | 4 studies | 19% ± 1% | |
| oligodendrocyte | 4 studies | 27% ± 7% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 24% ± 2% | |
| GABAergic interneuron | 3 studies | 21% ± 4% | |
| granule cell | 3 studies | 20% ± 3% | |
| retinal ganglion cell | 3 studies | 25% ± 1% | |
| myeloid cell | 3 studies | 17% ± 2% | |
| club cell | 3 studies | 19% ± 2% | |
| ciliated cell | 3 studies | 23% ± 4% | |
| lymphocyte | 3 studies | 26% ± 8% | |
| hepatocyte | 3 studies | 35% ± 20% | |
| connective tissue cell | 3 studies | 18% ± 1% | |
| monocyte | 3 studies | 16% ± 1% | |
| adipocyte | 3 studies | 17% ± 2% |
